Qingdao Vland Biotech INC. (SHA:603739)

Market Cap	4.01B
Revenue (ttm)	1.39B
Net Income (ttm)	83.57M
Shares Out	253.03M
EPS (ttm)	0.33
PE Ratio	47.76
Forward PE	47.97
Dividend	0.10 (0.64%)
Ex-Dividend Date	May 30, 2025

Volume	5,874,840
Average Volume	9,360,925
Open	15.70
Previous Close	15.68
Day's Range	15.65 - 15.83
52-Week Range	11.65 - 18.41
Beta	0.48
RSI	59.57
Earnings Date	Apr 25, 2026

About SHA:603739

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antivir...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 1,535
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603739

Financial Performance

In 2024, SHA:603739's revenue was 1.32 billion, an increase of 10.16% compared to the previous year's 1.20 billion. Earnings were 62.64 million, a decrease of -22.39%.